Mar 21, 2016 10:37 AM

FDA approves new injection to combat anthrax

The Associated Press

WASHINGTON (AP) Federal health officials have approved a new injectable drug to treat patients who have been exposed to the deadly toxin anthrax.

The Food and Drug Administration said it approved Anthim on Friday to treat inhalation anthrax, which can cause serious injury and death. The condition occurs when anthrax bacterial spores are inhaled.

Because anthrax is a potential bioterrorism weapon the U.S. government has been funding the development and production of therapies.

Anthim was developed by Elusys Therapeutics Inc. of Pine Brook, New Jersey, with support from the Biomedical Advanced Research and Development Authority. The government agency stockpiles vaccines, drugs and equipment for use during pandemics and other health emergencies.

--  Dealing with the Disease of Addiction? Click here for help --

--

»Comments

Must Read on NH1.com

Concord, NH
Broken Clouds 43°
2pm 46°
3pm 46°
4pm 45°
5pm 45°

 

N.H. DollarSaver

 Wednesday, 2 p.m. - A surprise for 1 NH 4th-grade class, when they receive a state award

 

 

NH1 on Facebook

Download NH1 App

NH1 on Twitter

Check out NH1 News Rail Polls on LockerDome on LockerDome